Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin E-Mediated Allergic Disorder”

Showing 15 of 0 results

Not applicableStudy completedNCT06273605
What this trial is testing

The Egg Up Trial - Testing a New Treatment Pathway for Infants With Newly Diagnosed Egg Allergy

Who this might be right for
Food AllergyFood Allergy in Infants
Murdoch Childrens Research Institute 109
Early research (Phase 1)Study completedNCT00107705
What this trial is testing

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 12
Early research (Phase 1)UnknownNCT03819881
What this trial is testing

A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

Who this might be right for
Atopic Immunoglobulin E-Mediated Allergic Disorder
Siolta Therapeutics, Inc. 60
Not applicableStudy completedNCT05702671
What this trial is testing

Kenota 1 CWS Method Comparison Validation Study

Who this might be right for
AllergyImmunoglobulin E-Mediated Allergic Disorder
Kenota Inc. 411
Not applicableStudy completedNCT03553251
What this trial is testing

Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.

Who this might be right for
HypersensitivityBeta Lactam Adverse Reaction
Nantes University Hospital 195
Large-scale testing (Phase 3)Study completedNCT00414141
What this trial is testing

Efficacy and Safety/Tolerability of Grass MATA MPL

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 1,028
Testing effectiveness (Phase 2)UnknownNCT04492683
What this trial is testing

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

Who this might be right for
Cow's Milk Allergy
DBV Technologies 230
Testing effectiveness (Phase 2)Study completedNCT00104377
What this trial is testing

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 70
Not applicableStudy completedNCT05824637
What this trial is testing

Validation and Reproducibility of S.P.A.T. With Allergens

Who this might be right for
Allergy to House DustAllergy Pollen
Hippocreates 112
Early research (Phase 1)Study completedNCT01257191
What this trial is testing

Compare the Effects of Different Sized Particles on Cells in the Nose

Who this might be right for
Hypersensitivity, ImmediateAtopic Hypersensitivity
University of California, Los Angeles 25
Large-scale testing (Phase 3)Study completedNCT02636699
What this trial is testing

Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy

Who this might be right for
Peanut Allergy
DBV Technologies 500
Testing effectiveness (Phase 2)Study completedNCT00113750
What this trial is testing

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 70
Early research (Phase 1)Study completedNCT00241410
What this trial is testing

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 86
Early research (Phase 1)WithdrawnNCT00109759
What this trial is testing

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00110786
What this trial is testing

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 240

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation